CONTENTS:
- A qualitative exploration of Thai alcohol policy in regulating availability and access. Kaewpramkusol R., Senior K., Chenhall R., Nanthamongkolchai S., Chaiyasong S., p. 1-8.
- E-cigarette nicotine content and labelling practices in a restricted market: Findings from Ontario, Canada. Czoli C.D., Goniewicz M.L., Palumbo M., White C.M., Hammond D., p. 9-12.
- The role of alcohol in constructing gender & class identities among young women in the age of social media. Lennox J., Emslie C., Sweeting H., Lyons A., p. 13-21.
- Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar. O'Keefe D., Aung S.M., Pasricha N., Wun T., Linn S.K., Lin N., et al., p. 22-30.
- Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it? McGowan C.R., Harris M., Platt L., Hope V., Rhodes T., p. 31-36.
- Disneyization: A framework for understanding illicit drug use in bounded play spaces. Turner T., p. 37-45.
- "Once I'd done it once it was like writing your name": Lived experience of take-home naloxone administration by people who inject drugs. McAuley A., Munro A., Taylor A., p. 46-54.
- Prospective associations between cannabis use and negative and positive health and social measures among emerging adults. Korn L., Haynie D.L., Luk J.W., Simons-Morton B.G., p. 55-63.
- Quantity fluctuations of illicitly used opioids and overdose risk. Rowe C., Wheeler E., Vittinghoff E., Santos G.-M., Behar E., Coffin P.O., p. 64-70.
- Alcohol-related absence and presenteeism: Beyond productivity loss. Buvik K., Moan I.S., Halkjelsvik T., p. 71-77.
- 'Nice people doing shady things': Drugs and the morality of exchange in the darknet cryptomarkets. Masson K., Bancroft A., p. 78-84.
- Agricultural innovations in Morocco's cannabis industry. Chouvy P.-A., Macfarlane J., p. 85-91.
- The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overview. Coomber R., Moyle L., Belackova V., Decorte T., Hakkarainen P., Hathaway A., et al., p. 93-103.
- Pharmacological cognitive enhancement among non-ADHD individuals - A cross-sectional study in 15 countries. Maier L.J., Ferris J.A., Winstock A.R., p. 104-112.
- An altered state? Emergent changes to illicit drug markets and distribution networks in Scotland. Densley J., McLean R., Deuchar R., Harding S., p. 113-120.
- The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation. Castaldelli-Maia J.M., Martins S.S., Walker N., p. 121-125.
- Development and validation of the scale to assess satisfaction with medications for addiction treatment - Buprenorphine-naloxone for heroin addiction (SASMAT-BUNHER). Pérez de los Cobos J., Trujols J., Alcaraz S., Sinol N., Lozano Ó., Gonzalez-Saiz F., p. 126-134.
- Aging, multimorbidity, and substance use disorders: The growing case for integrating the principles of geriatric care and harm reduction. Han B.H., p. 135-136.
- Going knock - Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium). Grund J.-P., de Bruin D., van Gaalen S., p. 137-148.
- Assessing the effectiveness of New York's 911 Good Samaritan Law - Evidence from a natural experiment. Nguyen H., Parker B.R., p. 149-156.
- (Mis)understanding the intersection between development policies and data collection: Experiences in Afghanistan. Mansfield D., p. 157-165.